Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Post a clear PR regarding Pourhassan's sale of sto

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153821
(Total Views: 726)
Posted On: 05/04/2020 1:36:38 PM
Posted By: the lawman
Post a clear PR regarding Pourhassan's sale of stock.

Pourhassan’s muddled explanation regarding his sale of stock in today's Pro Active interview created more questions than answers, which, I believe, is why it had no positive effect upon the share price.

If Pourhassan sold his stock solely to pay for the exercise of options or warrants so the company would have enough money to pay Samsung to manufacture leronlimab, he should have said so.

Damage control is now needed in the form of a press release that should say something such as the following:

“The company wishes to clarify the reasons for the sale of Cytodyn stock by Dr. Nader Pourhassan on April___, 2020.

Although Dr. Pourhassan sold ___shares of Cytodyn stock at that time, 100% of the sale proceeds, in the amount of $_____, were used to pay for the exercise of Dr. Pourhassan’s options/warrants.

The proceeds paid to the company by Dr. Pourhassan, from the exercise of his options/warrants, will be used to pay Samsung Biologics to produce 1.2 million vials of leronlimab.

Without Dr. Pourhassan’s sale of stock and exercise of options/warrants, the company would not have been able to pay Samsung to manufacture leronlimab without a dilutive capital raise.”

My opinion, for what its worth.

LM


(12)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


The Lawmanstyle="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us